|
|
|
|
|
|
|
PoC Capital seeks to
invest in small, public life science companies whose product candidates have
the opportunity to improve patient well-being. Strong management teams, clear
mechanisms of action, and well-validated product development plans are key
components of our investment thesis. PoC
Capital specifically provides funding for companies to execute
proof-of-concept clinical trials, which serve to unlock the value of
development-stage assets through safety and efficacy validation. |
||
|
||
For more
information, or to understand if your company fits our investment parameters,
please feel free to email us at info@poccap.com.
|
|